MINERAL OIL 95 VISCOSITY- mineral oil liquid

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Buy It Now

Active ingredient:

MINERAL OIL (UNII: T5L8T28FGP) (MINERAL OIL - UNII:T5L8T28FGP)

Available from:

Aspen Veterinary

INN (International Name):

MINERAL OIL

Composition:

MINERAL OIL 854.5 g in 1 L

Administration route:

ORAL

Prescription type:

OTC

Therapeutic indications:

Livestock Drug A mild laxative for the lubrication of the intestinal tract.

Product summary:

ABILIFY® (aripiprazole) Tablets have markings on one side and are available in the strengths and packages listed in Table 15. ABILIFY DISCMELT® (aripiprazole) Orally Disintegrating Tablets are round tablets with markings on either side. ABILIFY DISCMELT is available in the strengths and packages listed in Table 16. ABILIFY® (aripiprazole) Oral Solution (1 mg/mL) is supplied in child-resistant bottles along with a calibrated oral dosing cup. ABILIFY Oral Solution is available as follows: ABILIFY® (aripiprazole) Injection for intramuscular use is available as a ready-to-use, 9.75 mg/1.3 mL (7.5 mg/mL) solution in clear, Type 1 glass vials as follows: Tablets Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Oral Solution Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Opened bottles of ABILIFY Oral Solution can be used for up to 6 months after opening, but not beyond the expiration date on the bottle. The bottle and its contents should be discarded after the expiration date. Injection Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light by storing in the original container. Retain in carton until time of use.

Authorization status:

unapproved drug other

Patient Information leaflet

                                ABILIFY - ARIPIPRAZOLE TABLET
H.J. Harkins Company, Inc.
----------
MEDICATION GUIDE
ABILIFY® (a BIL ĭ fī)
Generic name: aripiprazole
Read this Medication Guide before you start taking ABILIFY and each
time you get a refill. There may
be new information. This Medication Guide does not take the place of
talking to your healthcare provider
about your medical condition or treatment.
What is the most important information I should know about ABILIFY?
(For other side effects, also see “What are the possible side
effects of ABILIFY?”).
Serious side effects may happen when you take ABILIFY, including:
•
Increased risk of death in elderly patients with dementia-related
psychosis: Medicines like
ABILIFY can raise the risk of death in elderly people who have lost
touch with reality (psychosis)
due to confusion and memory loss (dementia). ABILIFY is not approved
for the treatment of
patients with dementia-related psychosis.
•
Risk of suicidal thoughts or actions: Antidepressant medicines,
depression and other serious
mental illnesses, and suicidal thoughts or actions:
1.
Antidepressant medicines may increase suicidal thoughts or actions in
some children,
teenagers, and young adults within the first few months of treatment.
2.
Depression and other serious mental illnesses are the most important
causes of suicidal
thoughts and actions. Some people may have a particularly high risk of
having suicidal
thoughts or actions. These include people who have (or have a family
history of) bipolar
illness (also called manic-depressive illness) or suicidal thoughts or
actions.
3.
How can I watch for and try to prevent suicidal thoughts and actions
in myself or a family
member?
•
Pay close attention to any changes, especially sudden changes, in
mood, behaviors,
thoughts, or feelings. This is very important when an antidepressant
medicine is
started or when the dose is changed.
•
Call the healthcare provider right away to report new or sudden
changes in mood,
behavior, thoughts, or feelings.
•
Keep all follow-up visits wit
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                MINERAL OIL 95 VISCOSITY- MINERAL OIL LIQUID
ASPEN VETERINARY
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
MINERAL OIL
95 VISCOSITY
LIVESTOCK DRUG
FOR ANIMAL USE ONLY
KEEP OUT OF REACH OF CHILDREN
CAUTION:
Exercise care in administering to avoid aspiration into the lungs and
possible foreign
body pneumonia. Prolonged use or frequent repeated use may interfere
with normal
absorption of nutrients from the digestive tract.
DOSE CHART
Horses .................................................... 1 pt
Cattle ......................................................1 pt
Sheep .................................................... 5 oz
Hogs....................................................... 1 pt
Dogs
Toy breeds ......................................... 1 oz
Puppies.............................................. 1 oz
Adult Dogs ......................................... 2 oz
According to size.
INDICATIONS:
A mild laxative for the lubrication of the intestinal tract.
INGREDIENT:
Mineral Oil ..........................................100%
WARNING:
Not recommended for frequent repeated or extended repeated
administration. If
condition persists consult veterinarian.
STORAGE:
Store at controlled room temperature between 15°-30°C (59°-86°F).
KEEP CONTAINER TIGHTLY CLOSED, PROTECT FROM LIGHT.
NET CONTENTS:
1 Gallon (3.785 L)
A225FP Rev. 10/12
Manufactured for:
Aspen Veterinary Resources,® Ltd.
Liberty, MO 64068, USA
MINERAL OIL 95 VISCOSITY
mineral oil liquid
PRODUCT INFORMATION
PRODUCT TYPE
OTC ANIMAL DRUG
ITEM CODE (SOURCE)
NDC:46066-234
ROUTE OF ADMINISTRATION
ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRENGTH
MINERAL OIL (UNII: T5L8T28FGP) (MINERAL OIL - UNII:T5L8T28FGP)
MINERAL OIL
854.5 g in 1 L
Aspen Veterinary
PACKAGING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1 NDC:46066-234-01
4 in 1 CASE
1
3.785 L in 1 JUG
M
                                
                                Read the complete document
                                
                            

Search alerts related to this product